Erez Chimovits
Erez Chimovits has made 1 open-market purchase worth $1.0M since Sep 30, 2026, in 1 company. The latest: $1.0M of ADRX, filed Sep 30, 2026, scored 54 out of 100.
Director, ADARx Pharmaceuticals, Inc.
Follow Erez Chimovits, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 30 Form 4 (opens sec.gov) |
ADRXADARx Pharmaceuticals, Inc. · DirectorDirector · 5 insiders buying | +1% stake | 54 | $1.0M 61,516 at $17.00 |
−9.5% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −9.5% (0% up, 1 measured).
Questions
What stock has Erez Chimovits bought?
ADRX (ADARx Pharmaceuticals, Inc.), all on the open market and reported on SEC Form 4.
When did Erez Chimovits last buy?
Sep 30, 2026: 61,516 shares of ADRX at $17.00, $1.0M in all (Form 4 (opens sec.gov)).
Has Erez Chimovits filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Erez Chimovits a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer